eJIAS and the Bristol-Myers Squibb Foundation's Secure the Future Program
نویسنده
چکیده
Secure the Future, Bristol-Myers Squibb's landmark $115 million program to offer care and support for the women and children affected and infected by HIV/AIDS in 9 countries in Southern and Western Africa, recently marked its 5-year anniversary. During that time it has supported nearly 200 programs in these countries to offer new approaches to medical research and care and community outreach and education, especially in resourcelimited settings. These projects have included new studies focusing on mother-to-child transmission of HIV after birth, the development of CD4 tests that have reduced costs by up to 80%, the first HIV reference laboratory for HIV diagnosis and testing in Botswana, the first pediatric HIV/AIDS treatment and research center in Africa, and a groundbreaking healthcare training curriculum in HIV/ AIDS, along with scores of projects supporting homebased care, counseling, prevention, destigmatization and education, income generation, nutritional support, and much more. In each project, the aim has been to find ways to create sustainable solutions that are appropriate for each setting and to do so in ways that build capacity for the future in each of these areas. Secure the Future recently opened a series of comprehensive community-based treatment and support centers to serve as model programs through which newly available antiretroviral treatments can be delivered, while at the same time offering the kind of community-based support and resources, from counseling to home-based care, that will be required if these treatments are to truly succeed.
منابع مشابه
Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery.
Bristol Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08534, Bristol-Myers Squibb, Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, Bristol Myers Squibb, Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543, and Bristol-Myers Squibb, Pharmaceutical Research Institute, One Squibb Drive, New Bru...
متن کاملIntroduction: the art and science of switching antipsychotic medications.
From the Department of Psychiatry, Medical College of Georgia, Augusta. The curriculum roundtable “The Art and Science of Switching Antipsychotic Medications” was held January 21, 2006, in Atlanta, Ga., and supported by an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. Dr. Buckley is a consultant for Abbott, Alamo, AstraZeneca, Bristol-Myers Squibb, ...
متن کاملMaking a public-private partnership work--an insider's view. Interview by John Maurice.
In November 1999, Dr Amadou Diarra was appointed senior director of Bristol-Myers Squibb's Secure the Future Initiative. Launched 18 months ago, this public-private partnership is seeking, together with the governments of nine African countries, innovative ways of reducing the transmission and the impact of HIV/AIDS, especially on women and children, through interventions involving medical care...
متن کاملristol-Myers Squibb Pharmaceutical esearch Institute
Bristol-Myers Squibb is a diversified worldwide health and personal care company with principal businesses in pharmaceuticals, consumer medicines, nutritionals and medical devices. We are a leader in the research and development of innovative therapies for cardiovascular, metabolic and infectious diseases, neurological disorders, and oncology. In 2001 alone, Bristol-Myers Squibb dedicated $2.1 ...
متن کامل